Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last --
Change Today 0.00 / 0.00%
Volume 0.0
4543 On Other Exchanges
Symbol
Exchange
4543 is not on other exchanges.
All times are local (Market data is delayed by at least 15 minutes).

terumo corp (4543) Snapshot

Open
--
Previous Close
--
Day High
--
Day Low
--
52 Week High
-- - --
52 Week Low
-- - --
Market Cap
--
Average Volume 10 Days
0.0
EPS TTM
--
Shares Outstanding
0.0
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for TERUMO CORP (4543)

Related News

No related news articles were found.

terumo corp (4543) Related Businessweek News

No Related Businessweek News Found

terumo corp (4543) Details

Terumo Corporation manufactures and sells medical products and equipment worldwide. The company operates through Cardiac & Vascular, General Hospital, and Blood Management segments. Its cardiac and vascular products primarily comprise interventional devices that include access devices, such as introducer sheaths, guidewires, and guiding catheters; therapeutic devices, which include balloon catheters and stents; intravascular imaging systems; and cardiopulmonary bypass systems comprising oxygenator with integrated arterial filters, heart-lung machines, and artificial thoracic vascular grafts. The company’s general hospital products principally include infusion systems, including infusion pumps, infusion solutions, IV catheter, and infusion line connectors; drug and devices comprising prefilled syringes and prefillable syringes; nutritional supplements; measuring devices systems with communication functions, such as blood glucose meters, blood pressure monitors, and thermometers; pain management medicines that include analgesic and antiemetic; and closed anticancer drug infusion systems. Its blood management products primarily comprise automated blood collection systems, blood bag systems with leukocyte reduction filters, automated blood component processing system, pathogen reduction technology systems, therapeutic apheresis systems, and cell expansion systems. The company was formerly known as Sekisen Ken-onki Corporation and changed its name to Terumo Corporation in October 1974. Terumo Corporation was founded in 1921 and is headquartered in Tokyo, Japan.

Founded in 1921

terumo corp (4543) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

terumo corp (4543) Key Developments

Olympus Partners with Terumo Corporation to Distribute GLIDEWIRE Urologic Hydrophilic Coated Guidewire

Olympus announced that it has partnered with Terumo Corporation to be the exclusive distributor of the GLIDEWIRE Urologic Hydrophilic Coated Guidewire. Beginning immediately, the Olympus Urology and Stone Management sales force will distribute the device to U.S. customers. Guidewires produced by Terumo Corporation will be supplied by its U.S. subsidiary, Terumo Medical Corporation, for Olympus' U.S. subsidiary, Olympus Medical Systems Group. Through the partnership, Terumo Corporation will benefit from the U.S. presence and marketing arm of Olympus in Urology, and Olympus will benefit from the guidewire quality and reputation of Terumo Corporation. The GLIDEWIRE Urologic Guidewire is used during minimally invasive urology procedures such as ureteroscopies, percutaneous nephrolithotomy (PCNL) and lithotripsy procedures to help advance devices and enable easy tracking of urological instruments, catheters and stents.

Terumo Corporation Announces Consolidated Earnings Results for the Year Ended March 31, 2015; Provides Consolidated Earnings Guidance for the Half Year Ending September 30, 2015, the Fiscal Year Ending March 31, 2016 and 2017; Provides Dividend Guidance for the Half Year Ending September 30, 2015 and the Fiscal Year Ending March 31, 2016

Terumo Corporation reported consolidated earnings results for the year ended March 31, 2015. For the year, the company reported net sales of JPY 489,506 million against JPY 467,359 million a year ago. Operating income was JPY 67,456 million against JPY 65,288 million a year ago. Ordinary income was JPY 70,730 million against JPY 63,802 million a year ago. Net income was JPY 38,470 million against JPY 34,096 million a year ago. Diluted net income per share was JPY 99.12 against JPY 89.78 a year ago. Income before income taxes and minority interests was JPY 64,046 million against JPY 52,907 million a year ago. Income before minority interests was JPY 38,470 million against JPY 34,126 million a year ago. Net assets per share, as of March 31, 2015 were JPY 1,513.73 against JPY 1,306.72 a year ago. Cash flows from operating activities were JPY 73,110 million against JPY 96,259 million a year ago. Purchase of property, plant and equipment was JPY 37,342 million against JPY 39,933 million a year ago. Purchase of intangible assets was JPY 3,683 million against JPY 4,960 million a year ago. The company provided consolidated earnings guidance for the half year ending September 30, 2015, the fiscal year ending March 31, 2016 and 2017. For the half year ending September 30, 2015, the company expects net sales of JPY 250,000 million, operating income of JPY 31,000 million, ordinary income of JPY 29,500 million, net income of JPY 17,500 million and net income per share of JPY 46.09. For the fiscal year ending March 31, 2016, the company expects net sales of JPY 520,000 million, operating income of JPY 70,000 million, ordinary income of JPY 67,000 million, net income of JPY 39,500 million and net income per share of JPY 104.04. For the half year ending September 30, 2015, the company expects dividend per share of JPY 16.00 against JPY 14.50 a year ago. For the fiscal year ending March 31, 2016, the company expects year-end dividend per share of JPY 16 and full fiscal year dividend per share of JPY 30 against year-end dividend per share of JPY 16 and full fiscal year dividend per share of JPY 32 a year ago. The company announced a goal of 20% operating profit, excluding goodwill amortization by fiscal 2017.

Terumo Corporation to Report Fiscal Year 2015 Results on May 08, 2015

Terumo Corporation announced that they will report fiscal year 2015 results on May 08, 2015

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
4543:JP ¥2,870.00 JPY -6.00

4543 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
CR Bard Inc $170.41 USD -1.54
Edwards Lifesciences Corp $128.56 USD -2.32
Hospira Inc $88.34 USD +0.07
Olympus Corp ¥4,185 JPY +10.00
Teleflex Inc $127.45 USD -2.27
View Industry Companies
 

Industry Analysis

4543

Industry Average

Valuation 4543 Industry Range
Price/Earnings 28.7x
Price/Sales 2.2x
Price/Book 1.9x
Price/Cash Flow 28.1x
TEV/Sales 1.4x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact TERUMO CORP, please visit www.terumo.co.jp. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.